Topo Therapeutics

Cambridge, MA · Founded 2024 · Privately Held (backing)

Operator of small molecule therapeutics intended to accelerate transmembrane protein drug discovery. Topo Therapeutics is based in Cambridge, MA and was founded in 2024. It was valued at $138 million at its early-stage round in Dec 2024, the last priced event on record. It has raised $10.6 million across 1 recorded round; the latest was a $10.6 million early-stage round in Dec 2024.

PMV mark · valuation
$137.6M
Oct 2026
Priced at
its early-stage round
Dec 2024
Total raised
$10.6M
Last round
Early Stage VC
Dec 2024
How much has Topo Therapeutics raised?
$10.6Macross 1 recorded rounds · Dec 2024 – Dec 2024

Most recently, Topo Therapeutics raised $10.6M in its Early Stage VC (Dec 2024).

Free account
More of Topo Therapeutics with a free account
  • ·Watch Topo Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Topo Therapeutics round by round

1 rounds
Dec 2024Early Stage VC$10.6MSEC filing▮
4 investors participated

How much has Topo Therapeutics raised?

Topo Therapeutics has raised $10.6 million across 1 recorded round since 2024. The largest was a $10.6 million early-stage round in Dec 2024.

Topo Therapeutics has filed 2 Form Ds with the SEC, most recently in Dec 2024 ($10.6 million sold to 4 investors).

Topo Therapeutics investors

3 investors are on record for Topo Therapeutics, including SR One Capital Management, MRL Ventures Fund and The Column Group. The early-stage round in Dec 2024 drew 4 investors.

For fundraisers
Raising for a company like Topo Therapeutics?

3 investors have backed Topo Therapeutics.

See all 3 investors →

Frequently asked about Topo Therapeutics

How much has Topo Therapeutics raised?
Topo Therapeutics has raised $10.6M in total across 1 recorded funding rounds.
When was Topo Therapeutics's last funding round?
Topo Therapeutics's most recent recorded round was Early Stage VC in Dec 2024, raising $10.6M.